These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 24893756)

  • 1. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
    Bryant RV; Jairath V; Curry N; Travis SP
    J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Nguyen GC; Murthy SK; Bressler B; Lam MCW; Alali A; Toumi A; Reinglas J; Rampersad A; Weizman AV; Afif W;
    Inflamm Bowel Dis; 2017 May; 23(5):695-701. PubMed ID: 28426451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
    Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic complications in inflammatory bowel diseases.
    Fornaro R; Caristo G; Stratta E; Caratto M; Caratto E; Giovinazzo D; Di Maira L; Casaccia M; Frascio M
    G Chir; 2019; 40(1):14-19. PubMed ID: 30771793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.
    Baser O; Liu X; Phatak H; Wang L; Mardekian J; Kawabata H; Petersel D; Hamilton M; Ramacciotti E
    Am J Ther; 2013; 20(2):132-42. PubMed ID: 23466619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Scoville E; Konijeti GG; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1905-10. PubMed ID: 24632349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism in patients with inflammatory bowel disease.
    Koutroumpakis EI; Tsiolakidou G; Koutroubakis IE
    Semin Thromb Hemost; 2013 Jul; 39(5):461-8. PubMed ID: 23629820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Faye AS; Hung KW; Cheng K; Blackett JW; Mckenney AS; Pont AR; Li J; Lawlor G; Lebwohl B; Freedberg DE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1394-1400. PubMed ID: 31689354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis following hip and knee arthroplasty.
    Mirkazemi C; Bereznicki LR; Peterson GM
    Intern Med J; 2013 Feb; 43(2):124-9. PubMed ID: 23402484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
    Murthy SK; Robertson McCurdy AB; Carrier M; McCurdy JD
    Thromb Res; 2020 Oct; 194():26-32. PubMed ID: 32563061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.